These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4085074)

  • 1. Pharmacokinetic studies of the inhibition of glucuronization of pentazocine by salicylamide.
    Yumita N; Nishigaki R; Umemura K; Hayashi T; Kigasawa K
    Chem Pharm Bull (Tokyo); 1985 Aug; 33(8):3436-9. PubMed ID: 4085074
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biopharmaceutical studies of drugs. I. Effect of salicylamide on serum concentration of pentazocine after oral administration (author's transl)].
    Kigasawa K; Shimizu H; Saito M; Hayashi T; Tanaka M
    Yakugaku Zasshi; 1980 Mar; 100(3):244-8. PubMed ID: 7381684
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biopharmaceutical studies of drugs. II. The competitive inhibition of pentazocine glucuronidation by salicylamide in vitro (author's transl)].
    Kigasawa K; Shimizu H; Saito M; Hayashi T
    Yakugaku Zasshi; 1980 Mar; 100(3):249-55. PubMed ID: 7381685
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic studies on pentazocine.
    Mitchard M
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():172-80. PubMed ID: 5316399
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of product inhibition on elimination kinetics of ethoxybenzamide in rabbits. Analysis by physiological pharmacokinetic model.
    Lin JH; Sugiyama Y; Hanano M; Awazu S
    Drug Metab Dispos; 1984; 12(2):253-6. PubMed ID: 6144493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of salicylamide administration on D-glucuronic acid metabolism in the rat.
    Hänninen O
    Ann Acad Sci Fenn A; 1966; 123():1-66. PubMed ID: 5908696
    [No Abstract]   [Full Text] [Related]  

  • 7. [The behavior of beta-glucuronidase activity in the serum and glucuronic acid excretion under salicylamide load].
    Dohrmann RE; Uhles HJ; Maas G
    Klin Wochenschr; 1965 Sep; 43(17):946-50. PubMed ID: 5863563
    [No Abstract]   [Full Text] [Related]  

  • 8. Depression of salicylamide glucuronidation by bacterial lipopolysaccharide.
    Kushiya M; Hasegawa R; Komuro T; Isaka H
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):416-20. PubMed ID: 3594667
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucuronide formation in rainbow trout--effect of salicylamide on the acute toxicity, conjugation and excretion of 3-trifluoromethyl-4-nitrophenol.
    Lech JJ
    Biochem Pharmacol; 1974 Sep; 23(17):2403-10. PubMed ID: 4429574
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics and neurochemical effects of pentazocine and its optical isomers.
    Berkowitz B
    Adv Biochem Psychopharmacol; 1973; 8(0):495-501. PubMed ID: 4604901
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis.
    Neal EA; Meffin PJ; Gregory PB; Blaschke TF
    Gastroenterology; 1979 Jul; 77(1):96-102. PubMed ID: 447033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of plasma levels and metabolism on pharmacological activity: pentazocine.
    Berkowitz B
    Ann N Y Acad Sci; 1971 Jul; 179():269-81. PubMed ID: 5285378
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary glucuronic acid excretion in liver disease and the effect of a salicylamide load.
    BARNIVILLE HT; MISK R
    Br Med J; 1959 Feb; 1(5118):337-40. PubMed ID: 13618635
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of salicylic acid and salicylamide on sulfisoxazole disposition in rabbits].
    Imamura Y; Miyashita E; Otagiri M
    Yakugaku Zasshi; 1986 Dec; 106(12):1146-50. PubMed ID: 3559910
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative determination of pentazocine in plasma and of pentazocine and metabolites in urine.
    Pittman KA; Davison C
    J Pharm Sci; 1973 May; 62(5):765-9. PubMed ID: 4705681
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism and excretion of pentazocine in man.
    Berkowitz B; Way EL
    Clin Pharmacol Ther; 1969; 10(5):681-9. PubMed ID: 5808463
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetic analysis of pharmacological effects and drug disposition. II. Effects of salicylamide and afebrile rats.
    Kakemi M; Kobayashi T; Mamuro C; Ueda M; Koizumi T
    Chem Pharm Bull (Tokyo); 1976 Sep; 24(9):2254-7. PubMed ID: 991370
    [No Abstract]   [Full Text] [Related]  

  • 18. An analysis of the inter-subject variation in the metabolism of pentazocine.
    Vaughan DP; Beckett AH
    J Pharm Pharmacol; 1974 Oct; 26(10):789-98. PubMed ID: 4156537
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of pentazocine in the rhesus monkey.
    Pittman KA; Portmann GA
    J Pharm Sci; 1974 Jan; 63(1):84-8. PubMed ID: 4204346
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacokinetics of pentazocine and tripelennamine.
    Yeh SY; Todd GD; Johnson RE; Gorodetzky CW; Lange WR
    Clin Pharmacol Ther; 1986 Jun; 39(6):669-76. PubMed ID: 3709032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.